Skip to main content

Advertisement

Log in

α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma

  • Preclinical Study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Invasive lobular carcinoma (ILC) is more frequently lymph node positive than is invasive ductal carcinoma (IDC), and ILC cell infiltration shows distinctive histological characteristics, suggesting the action of ILC-specific invasion molecules. To identify such a molecule, we used a proteomic approach in the pseudopodia of MDA-MB-231 breast cancer cells. A pseudopodial constituent was identified using excimer laser ablation, two-dimensional difference gel electrophoresis, mass spectroscopy, and immunocytofluorescence. MDA-MB-231 cells were modified to express various levels of this constituent by transient transfection and were examined for pseudopodia formation and migratory abilities using wound healing and two-chamber assays. Immunohistochemical positivity of human breast cancer cells (56 ILCs and 21 IDCs) was compared with clinicopathological variables. An actin-binding adaptor protein, α-parvin, was found to localize to pseudopodia and to form focal adhesions in cells not induced to extend pseudopodia. Pseudopodial length and density and migratory abilities correlated with α-parvin expression. Twenty-one (37.5 %) ILCs stained positive for α-parvin, whereas the results were negative for all 21 IDCs (P < 0.001). α-Parvin positivity in ILC was significantly associated with lymphatic invasion (P = 0.038) and lymph node metastasis (P = 0.003) in univariate analyses and to lymph node metastasis (P = 0.020) in multivariate analyses. α-Parvin, a pseudopodial constituent, was found to promote migration of breast cancer cells and to be expressed exclusively by ILC, suggesting that α-parvin is an ILC-specific invasion molecule that may have clinical utility as a biomarker for aggressive subsets of ILC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

ILC:

Invasive lobular carcinoma

IDC:

Invasive ductal carcinoma

2D-DIGE:

Two-dimensional difference gel electrophoresis

LC–MS/MS:

Liquid chromatography-tandem mass spectroscopy

References

  1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (2012) WHO Classification of Tumors of the Breast. International Agency for Research on Cancer, Lyon, France

    Google Scholar 

  2. Wasif N, Maggard MA, Ko CY, Giuliano AE (2010) Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes. Ann Surg Oncol 17(7):1862–1869. doi:10.1245/s10434-010-0953-z

    Article  PubMed  Google Scholar 

  3. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi:10.1073/pnas.191367098

    Article  PubMed  Google Scholar 

  4. Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LF et al (2008) Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 216(2):141–150. doi:10.1002/path.2407

    Article  CAS  PubMed  Google Scholar 

  5. Weigelt B, Geyer FC, Natrajan R, Lopez-Garcia MA, Ahmad AS, Savage K et al (2010) The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J Pathol 220(1):45–57. doi:10.1002/path.2629

    Article  CAS  PubMed  Google Scholar 

  6. Lauffenburger DA, Horwitz AF (1996) Cell migration: a physically integrated molecular process. Cell 84(3):359–369

    Article  CAS  PubMed  Google Scholar 

  7. Bravo-Cordero JJ, Hodgson L, Condeelis J (2012) Directed cell invasion and migration during metastasis. Curr Opin Cell Biol 24(2):277–283. doi:10.1016/j.ceb.2011.12.004

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Ito A, Mimae T, Yamamoto YS, Hagiyama M, Nakanishi J, Ito M et al (2012) Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis. Lab Invest 92(9):1374–1385. doi:10.1038/labinvest.2012.98

    Article  CAS  PubMed  Google Scholar 

  9. Sepulveda JL, Wu C (2006) The parvins. Cell Mol Life Sci 63(1):25–35

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Nikolopoulos SN, Turner CE (2000) Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol 151(7):1435–1448

    Article  CAS  PubMed  Google Scholar 

  11. Olski TM, Noegel AA, Korenbaum E (2001) Parvin, a 42 kDa focal adhesion protein, related to the alpha-actinin superfamily. J Cell Sci 114(Pt 3):525–538

    CAS  PubMed  Google Scholar 

  12. Nikolopoulos SN, Turner CE (2002) Molecular dissection of actopaxin–integrin-linked kinase–Paxillin interactions and their role in subcellular localization. J Biol Chem 277(2):1568–1575

    Article  CAS  PubMed  Google Scholar 

  13. Yun SP, Ryu JM, Han HJ (2011) Involvement of β1-integrin via PIP complex and FAK/paxillin in dexamethasone-induced human mesenchymal stem cells migration. J Cell Physiol 226(3):683–692. doi:10.1002/jcp.22383

    Article  CAS  PubMed  Google Scholar 

  14. Kovalevich J, Tracy B, Langford D (2011) PINCH: More than just an adaptor protein in cellular response. J Cell Physiol 226(4):940–947. doi:10.1002/jcp.22437

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Devallière J, Chatelais M, Fitau J, Gérard N, Hulin P, Velazquez L et al (2012) LNK (SH2B3) is a key regulator of integrin signaling in endothelial cells and targets α-parvin to control cell adhesion and migration. FASEB J 26(6):2506–2592. doi:10.1096/fj.11-193383

    Article  Google Scholar 

  16. Clarke DM, Brown MC, LaLonde DP, Turner CE (2004) Phosphorylation of actopaxin regulates cell spreading and migration. J Cell Biol 166(6):901–912

    Article  CAS  PubMed  Google Scholar 

  17. Pignatelli J, LaLonde SE, LaLonde DP, Clarke D, Turner CE (2012) Actopaxin (α-parvin) phosphorylation is required for matrix degradation and cancer cell invasion. J Biol Chem 287(44):37309–37320. doi:10.1074/jbc.M112.385229

    Article  CAS  PubMed  Google Scholar 

  18. Mimae T, Okada M, Hagiyama M, Miyata Y, Tsutani Y, Inoue T et al (2012) Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages. Clin Cancer Res 18(4):945–955. doi:10.1158/1078-0432.CCR-11-1946

    Article  CAS  PubMed  Google Scholar 

  19. Thomas ZI, Gibson W, Sexton JZ, Aird KM, Ingram SM, Aldrich A et al (2011) Targeting GLI1 expression in human inflammatory breast cancer cells enhances apoptosis and attenuates migration. Br J Cancer 104(10):1575–1586. doi:10.1038/bjc.2011.133

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC (2011) Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 11:32. doi:10.1186/1471-2407-11-32

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Koma Y, Furuno T, Hagiyama M, Hamaguchi K, Nakanishi M, Masuda M et al (2008) Cell adhesion molecule 1 is a novel pancreatic-islet cell adhesion molecule that mediates nerve-islet cell interactions. Gastroenterology 134(5):1544–1554. doi:10.1053/j.gastro.2008.01.081

    Article  CAS  PubMed  Google Scholar 

  22. Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell Inc., New York

    Google Scholar 

  23. Kurosumi M (2007) Immunohistochemical assessment of hormone receptor status using a new scoring system (J-score) in breast cancer. Breast Cancer 14(2):189–193

    Article  PubMed  Google Scholar 

  24. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145

    Article  CAS  PubMed  Google Scholar 

  25. Turner CE (2000) Paxillin and focal adhesion signalling. Nat Cell Biol 2(12):E231–E236

    Article  CAS  PubMed  Google Scholar 

  26. van Horssen R, Hollestelle A, Rens JA, Eggermont AM, Schutte M, Ten Hagen TL (2012) E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells. Breast Cancer Res Treat 136(2):365–377. doi:10.1007/s10549-012-2261-8

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Yasumitsu Akahoshi (Kinki University) for technical assistance. This study was supported by the Japan Society for the Promotion of Science Kakenhi (24890274 and 25860302 to MH, 24659184 to TI, 24890137 to TM, 24390329 and 24659633 to MO, and 24590492 to AI), and grants from The Yasuda Medical Foundation and The Osaka Medical Research Foundation for Intractable Diseases. This work was partly carried out at the Analysis Center of Life Science, Natural Science Center for Basic Research and Development, Hiroshima University.

Conflict of interest

None.

Ethical standards

The ethics committee of Kinki University Faculty of Medicine approved the experimental protocol (No. 22-40).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akihiko Ito.

Additional information

Masaoki Ito and Man Hagiyama have contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 1796 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, M., Hagiyama, M., Mimae, T. et al. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma. Breast Cancer Res Treat 144, 59–69 (2014). https://doi.org/10.1007/s10549-014-2859-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-2859-0

Keywords

Navigation